TITLE

Thrombosis and hemostasis in renal disease

PUB. DATE
August 1994
SOURCE
Kidney International;Aug1994, Vol. 46 Issue 2, p287
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Discusses the initiation of normal thrombosis and hemostasis in renal disease. Exposure of subendothelial structures to flowing blood; Formation of solid hemostatic plug; Adhesion of platelets to the site of injury.
ACCESSION #
14888378

 

Related Articles

  • Course and resolution of the coagulopathy in nephrotic children. Alkjaersig, Norma; Fletcher, Anthony P.; Narayanan, Manoj; Robson, Alan M. // Kidney International;Mar1987, Vol. 31 Issue 3, p772 

    Blood coagulation function was serially studied in 84 children with nephrotic syndrome. Fifty-eight had minimal change disease, six had focal glomerulosclerosis and 20 had other forms of renal disease associated with the nephrotic syndrome. Qualitatively similar abnormalities in fibrinogen...

  • Megakaryocyte biology and related disorders. Pang, Liyan; Weiss, Mitchell J.; Poncz, Mortimer // Journal of Clinical Investigation;Dec2005, Vol. 115 Issue 12, p3332 

    Platelets, derived from megakaryocytes, have an essential role in thrombosis and hemostasis. Over the past 10 years, a great deal of new information has been obtained concerning the various aspects of hematopoiesis necessary to maintain a steady-state platelet level to support physiologic...

  • Recurrent left-leg venous thrombosis in a woman despite a therapeutic international normalized ratio. Sharaf, Mahmoud // CMAJ: Canadian Medical Association Journal;10/25/2005, Vol. 173 Issue 9, p1032 

    Presents the case of a 43-year-old woman with recurrent left-leg venous thrombosis. Diagnosis of the disease; Comparison of May-Thurner syndrome with deep-vein thrombosis; Information on May-Thurner syndrome.

  • Massive hemoptysis and deep venous thrombosis presenting in a woman with Hughes-Stovin syndrome: a case report. Al-Jahdali, Hamdan // Journal of Medical Case Reports;2010, Vol. 4 Issue 1, p1 

    Introduction: Hughes-Stovin syndrome is a very rare disease with fewer than 30 cases reported in the literature. The disease is thought to be a variant of Behcet's disease and is defined by the presence of pulmonary artery aneurysm in association with peripheral venous thrombosis. Case...

  • Different expression of the plasminogen activation system in renal thrombotic microangiopathy and the normal human kidney. Xu, Yichun; Hagege, Jacoueline; Mougenot, Béatrice; Sraer, Jean-Daniel; Rønne, Ebbe; Rondeau, Eric // Kidney International;Dec1996, Vol. 50 Issue 6, p2011 

    Renal thrombotic microangiopathy is characterized by glomerular and vascular thrombosis. The persistancy of fibrin deposits may result from imbalance between plasminogen activation and inhibition. In the present study, we used immunohistochemistry and in situ hybridization techniques to...

  • Letters to the Editor. Cohen, I. J.; Mammen, Eberhard F. // Clinical & Applied Thrombosis/Hemostasis;Fall1995, Vol. 1 Issue 4, p293 

    Presents letters to the editor referencing articles and topics discussed in previous issues. "Clinical and Applied Thrombosis/Hemostasis," which focused on hyperaggregation; Response to a letter to the editor concerning platelet hyperaggregability.

  • Announcements.  // Clinical & Applied Thrombosis/Hemostasis;Summer1995, Vol. 1 Issue 3, p241 

    Presents announcements from the board of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

  • Factor VIIa: Mounting evidence or anecdotal reports. MacLaren, R. // Journal of Postgraduate Medicine;Jan-Mar2007, Vol. 53 Issue 1, p4 

    The article focuses on the advantages and disadvantages of recombinant factor VIIa for the treatment of bleeding in hemophiliac patients. It offers a unique mechanism of action targeted at sites of exposed tissue factor and rapid reversal of anticoagulation. Thus, it effectively control...

  • The Involvement of Blood Coagulation Factor XIII in Fibrinolysis and Thrombosis. Muszbek, L.; Bagoly, Z.; Bereczky, Z.; Katona, É. // Cardiovascular & Hematological Agents in Medicinal Chemistry;2008, Vol. 6 Issue 3, p190 

    It has been known for a long time that blood coagulation factor XIII (FXIII) is essential for maintaining haemostasis, its deficiency leads to severe bleeding complication. Biochemical studies have revealed that FXIII is a key regulator of fibrinolysis and, in addition to its role in...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics